breast-cancer

Documents about breast-cancer

• The Impact of Obesity and Obesity Treatments on Breast Cancer#18559ClinicalTrials.gov
• Adaptive Symptom Self-Management Immunotherapy Study#18578ClinicalTrials.gov
• Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer#18621ClinicalTrials.gov
• Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure#18785ClinicalTrials.gov
• Role of Multi-modality Imaging in the Assessment of Chemotherapy Related Cardiac Dysfunction Among Cancer Patients#28296ClinicalTrials.gov
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer#28305ClinicalTrials.gov
• Autologous Natural Killer T Cells Infusion for the Treatment of Cancer#28337ClinicalTrials.gov
• Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.#28574ClinicalTrials.gov
• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA#67893ClinicalTrials.gov
• Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer#67894ClinicalTrials.gov
• SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)#121344ClinicalTrials.gov
• Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy#121370ClinicalTrials.gov
• Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer#121456ClinicalTrials.gov
• Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)#123450ClinicalTrials.gov
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors#123552ClinicalTrials.gov
• Metformin in Breast Cancer, Visualized With Positron Emission Tomography#332706ClinicalTrials.gov
• Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer#332741ClinicalTrials.gov
• The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy#332762ClinicalTrials.gov
• Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca#343697ClinicalTrials.gov
• Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients#346907ClinicalTrials.gov
• Brodalumab in the Treatment of Immune-Related Adverse Events#346915ClinicalTrials.gov
• HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer#346976ClinicalTrials.gov
• Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer#349969ClinicalTrials.gov
• A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies#353286ClinicalTrials.gov
• A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer#353297ClinicalTrials.gov
• Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer#356490ClinicalTrials.gov
• Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)#356552ClinicalTrials.gov
• Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer#366590ClinicalTrials.gov
• Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer#366617ClinicalTrials.gov
• Relationship between menopausal hormone therapy and incidence risk of breast cancer: systematic review and meta-analysis#4568Europe PMC
• Intake of the Total, Classes, and Subclasses of (Poly)phenols and Breast Cancer Risk: A Prospective Analysis of the EPIC Study#11656HAL (France)
• Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study#15438HAL (France)
• Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer#26211HAL (France)
• Physical activity barriers, facilitators, and preferences in primary and tertiary prevention of breast cancer: a French national observational study#68311HAL (France)
• Confocal Laser Microscopy for Intraoperative Margin Assessment in Breast-Conserving Surgery#280281HAL (France)
• Breast and cervical cancer screening in a semi-urban African setting: evidence from Franceville, Gabon (2015–2021)#284222HAL (France)
• Rôle de ALDH4A1 et du métabolisme de la proline dans la réponse aux stress métaboliques et au cancer#288107HAL (France)

Related topics